X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Priscilla VanderVeer

Priscilla VanderVeer Priscilla VanderVeer Priscilla VanderVeer is a vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Annapolis, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.

Recent Posts

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    May 6, 2016
Stopping opioid abuse – PhRMA and its members stand with patients, providers, law enforcement, policymakers and others in calling for and supporting national policies and action to address opioid...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    April 29, 2016
Fact Check Friday – When it comes to communications between with payers, biopharmaceutical companies are often constrained in sharing safety and efficacy information about medicines in...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    April 15, 2016
Competition works for pricing – Despite misleading claims to the contrary, a new report from IMS Institute for Healthcare Informatics found that net prices for brand medicines increased just 2.8...   Read More

Week in review: The latest from PhRMA

By Priscilla VanderVeer  |    April 8, 2016
11 years of PPA – This week, we celebrated the 11th anniversary of the Partnership for Prescription Assistance (PPA) by launching a mobile app.  The new app will offer a single point of access to...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    April 1, 2016
Discriminatory effect of insurance plan structure – New research from Harvard’s Center for Health Law and Policy Innovation (CHLPI) shows evidence that some insurance plans are designed to...   Read More

Week in review: The latest from PhRMA

By Priscilla VanderVeer  |    March 25, 2016
FDA quality metrics:  Building on our constructive ideas for improvements to the FDA’s recent proposal for a mandatory metrics program, we featured a guest blog post from Mairead Goetz, head of...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    March 18, 2016
ICYMI: Policy solutions for innovative treatment: Last week at our 2016 Annual Meeting, our president and CEO Steve Ubl discussed his vision for the organization and outlined policy solutions for...   Read More

What “value” means to me

By Priscilla VanderVeer  |    March 17, 2016
It’s March, which means it is National Kidney Month. More than 661,000 Americans have kidney failure. Every day, approximately 13 people die waiting for a kidney transplant. I am lucky to not be...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    March 4, 2016
Communications with health care professionals – A new paper from the Duke-Margolis Center for Health Policy rightly makes the argument in favor of establishing a more effective regulatory...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates